Publicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (5)

2022

  1. Limitations of Nature-Inspired Algorithms for Pricing on Digital Platforms

    Electronics (Switzerland), Vol. 11, Núm. 23

2021

  1. Flexibility and bed margins of the community of madrid’s hospitals during the first wave of the sars-cov-2 pandemic

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 7

2019

  1. Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2

    Journal of Clinical Oncology

2016

  1. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366

2015

  1. Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 15, Núm. 4, pp. 579-589